Global, reginal, national burden and risk factors in female breast cancer from 1990 to 2021

被引：10

作者：

Lan, Tian ^{[1
]}

Lu, Yunyan ^{[2
]}

He, Jiawei ^{[1
]}

Zhan, Chenni ^{[1
]}

Wang, Xiaojia ^{[3
,4
]}

Shao, Xiying ^{[3
,4
]}

Hu, Zujian ^{[1
]}

机构：

[1] Zhejiang Chinese Med Univ, Hangzhou Hosp Tradit Chinese Med, Hangzhou TCM Hosp, Dept Breast Surg, Hangzhou, Zhejiang, Peoples R China

[2] Wenzhou Med Univ, Peoples Hosp Xiaoshan Dist 1, Xiaoshan Affiliated Hosp, Dept Cardiol, Hangzhou, Zhejiang, Peoples R China

[3] Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Dept Med Oncol Breast Canc, Hangzhou, Peoples R China

[4] Chinese Acad Sci, Inst Canc & Basic Med IBMC, Hangzhou, Zhejiang, Peoples R China

来源：

ISCIENCE | 2024年 / 27卷 / 10期

关键词：

BODY-MASS INDEX; PHYSICAL-ACTIVITY; DISEASE; MORTALITY; TRENDS;

D O I：

10.1016/j.isci.2024.111045

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

This study was to assess the burden, trends, and risk factors associated with female breast cancer from 1990 to 2021 based on the Global Burden of Disease (GBD) 2021 study. In 2021, there were 20.32 million prevalent cases, 2.08 million incident cases, 0.66 million death cases, and 20.26 million disability-adjusted life years (DALYs). It presented an ascending trend in the age-standardized rates of prevalence and incidence over the past 32 years. The age-standardized DALYs rate (ASDR) increased slightly during 2012- 2021. The DALYs increase was primarily driven by population aging and growth. High red meat intake accounted for the highest proportion of ASDR. Breast cancer burden attributed to metabolic risks increased, especially in the regions with low social-development index (SDI) and limited health systems. Dietary, behavior, and metabolic risk factors should be controlled to diminish breast cancer burden, especially in countries with lower SDI.

引用

页数：13

共 38 条

[1]

Akram M, 2017, BIOL RES, V50

[2] The Global Breast Cancer Initiative: a strategic collaboration to strengthen health care for non-communicable diseases [J].

Anderson, Benjamin O. ;

Ilbawi, Andre M. ;

Fidarova, Elena ;

Weiderpass, Elisabete ;

Stevens, Lisa ;

Abdel-Wahab, May ;

Mikkelsen, Bente .

LANCET ONCOLOGY, 2021, 22 (05) :578-581

[3] Divergent estrogen receptor-positive and -negative breast cancer trends and etiologic heterogeneity in Denmark [J].

Anderson, William F. ;

Rosenberg, Philip S. ;

Petito, Lucia ;

Katki, Hormuzd A. ;

Ejlertsen, Bent ;

Ewertz, Marianne ;

Rasmussen, Birgitte B. ;

Jensen, Maj-Britt ;

Kroman, Niels .

INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (09) :2201-2206

[4] Effect of complementary and alternative medicine interventions on cancer related pain among breast cancer patients: A systematic review [J].

Behzadmehr, Razieh ;

Dastyar, Neda ;

Moghadam, Mahdieh Poodineh ;

Abavisani, Mahnaz ;

Moradi, Mandana .

COMPLEMENTARY THERAPIES IN MEDICINE, 2020, 49

[5] Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].

Bray, Freddie ;

Laversanne, Mathieu ;

Sung, Hyuna ;

Ferlay, Jacques ;

Siegel, Rebecca L. ;

Soerjomataram, Isabelle ;

Jemal, Ahmedin .

CA-A CANCER JOURNAL FOR CLINICIANS, 2024, 74 (03) :229-263

[6] RETRACTED: Metformin and Breast Cancer: Where Are We Now? (Retracted article. See vol. 26, 2025) [J].

Cejuela, Monica ;

Martin-Castillo, Begona ;

Menendez, Javier A. ;

Pernas, Sonia .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (05)

[7] A new method to attribute differences in total deaths between groups to population size, age structure and age-specific mortality rate [J].

Cheng, Xunjie ;

Tan, Liheng ;

Gao, Yuyan ;

Yang, Yang ;

Schwebel, David C. ;

Hu, Guoqing .

PLOS ONE, 2019, 14 (05)

[8]

Duarte MBO, 2022, JCO GLOB ONCOL, V8, DOI [10.1200/GO.21.00371, DOI 10.1200/GO.21.00371]

[9] Breast cancer in China [J].

Fan, Lei ;

Strasser-Weippl, Kathrin ;

Li, Jun-Jie ;

St Louis, Jessica ;

Finkelstein, Dianne M. ;

Yu, Ke-Da ;

Chen, Wan-Qing ;

Shao, Zhi-Ming ;

Goss, Paul E. .

LANCET ONCOLOGY, 2014, 15 (07) :E279-E289

[10] Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021 [J].

Ferrari, Alize J. ;

Santomauro, Damian Francesco ;

Aali, Amirali ;

Abate, Yohannes Habtegiorgis ;

Abbafati, Cristiana ;

Abbastabar, Hedayat ;

ElHafeez, Samar Abd ;

Abdelmasseh, Michael ;

Abd-Elsalam, Sherief ;

Abdollahi, Arash ;

Abdullahi, Auwal ;

Abegaz, Kedir Hussein ;

Zuniga, Roberto Ariel Abeldano ;

Aboagye, Richard Gyan ;

Abolhassani, Hassan ;

Abreu, Lucas Guimaraes ;

Abualruz, Hasan ;

Abu-Gharbieh, Eman ;

Abu-Rmeileh, Niveen M. E. ;

Ackerman, Ilana N. ;

Addo, Isaac Yeboah ;

Addolorato, Giovanni ;

Adebiyi, Akindele Olupelumi ;

Adepoju, Abiola Victor ;

Adewuyi, Habeeb Omoponle ;

Afyouni, Shadi ;

Afzal, Saira ;

Afzal, Sina ;

Agodi, Antonella ;

Ahmad, Aqeel ;

Ahmad, Danish ;

Ahmad, Firdos ;

Ahmad, Shahzaib ;

Ahmed, Ali ;

Ahmed, Luai A. ;

Ahmed, Muktar Beshir ;

Ajami, Marjan ;

Akinosoglou, Karolina ;

Akkaif, Mohammed Ahmed ;

Al Hasan, Syed Mahfuz ;

Alalalmeh, Samer O. ;

Al-Aly, Ziyad ;

Albashtawy, Mohammed ;

Aldridge, Robert W. ;

Alemu, Meseret Desalegn ;

Alemu, Yihun Mulugeta ;

Alene, Kefyalew Addis ;

Al-Gheethi, Adel Ali Saeed ;

Alharrasi, Maryam ;

Alhassan, Robert Kaba .

LANCET, 2024, 403 (10440) :2133-2161

← 1 2 3 4 →